Loading chat...
MN HF3609
Bill
Status
2/23/2026
Primary Sponsor
Natalie Zeleznikar
Click for details
AI Summary
-
Drug manufacturers remain prohibited from restricting delivery of 340B prescription drugs to eligible health care entities in Minnesota
-
Violations of the 340B drug delivery restrictions are classified as unfair or deceptive trade practices under Minnesota law (section 8.31, subdivision 1)
-
The Minnesota Attorney General is granted authority to enforce violations of the 340B drug delivery requirements
-
The existing July 1, 2027 expiration date for the 340B drug access law (section 62J.96) is repealed, making the protections permanent
Legislative Description
Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed.
Last Action
Author added Anderson, P. H.
3/16/2026